Press release
Epitranscriptomics Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity
Epitranscriptomics Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Epitranscriptomics Market Research Report: https://marketgenics.co/press-releases/epitranscriptomics-market-70679
Global Epitranscriptomics Market Forecast 2035:
According to the report, the global epitranscriptomics market is projected to expand from USD 0.8 billion in 2025 to USD 3.0 billion by 2035, registering a CAGR of 14.3%, the highest during the forecast period. The epitranscriptomics market is experiencing a fast growth across the world where RNA modification is becoming one of the most important regulators of gene expression, cellular functions and the pathogenesis of diseases. This new science is leading to breakthroughs in precision medicine, which makes it possible to design targeted treatment to cancer, neurological diseases, metabolic diseases, and rare genetic diseases. The m6A sequencing, RNA methylation profiling, and single-cell epitranscriptomics technologies are driving the basic research and clinical use, providing scientists with the opportunity to discover novel biomarkers and therapeutic targets.
Epitranscriptomics is receiving huge investments in major research institutions, pharmaceutical companies, and biotech startups aiming to discover it faster with the use of next-generation sequencing, mass spectrometry, and advanced bioinformatics. North America has taken center stage with its well-developed research base, capital and biotech ecosystem whereas Asia-Pacific is up-and-coming with the government investment, increased research potential and entrepreneurial innovation. Technological advances, enhancement of translational research, and growth in the use of individualized medicine methods have contributed to the growth of the market and made epitranscriptomics an essential part of next-generation therapeutics and diagnostics in the world.
"Key Driver, Restraint, and Growth Opportunity Shaping the Global Epitranscriptomics Market"
The rising interest in personalized and precision medicine is a key catalyst of the epitranscriptomics market. Knowledge of RNA modifications can enable scientists and pharmaceutical firms to create targeted treatments to cancer, neurological diseases, metabolic diseases, and rare hereditary diseases. State-of-the-art technologies like m6A sequencing, RNA methylation profiling, and single-cell epitranscriptomics make it possible to identify new biomarkers more quickly in the development of therapies and enhance patient outcomes.
The epi-transcriptomics is the study of various types of RNA modification that have different chemical properties and biological functions, and it is inherently complex to analyze them. Sample preparation, detection and bioinformatic pipelines may vary resulting in laboratories having different results. The absence of generally accepted protocols and reference standards reduces reproducibility and extensive clinical implementation, making it difficult to translate research findings into effective diagnostics and therapeutic strategies.
Artificial intelligence and machine learning, combined with advanced bioinformatics tools, and next-generation sequencing are all opening up important possibilities in epitranscriptomics. These technologies can greatly enhance biomarker discovery and discovery of therapeutic targets by making the process of RNA modifications much faster and more precise. This integration will increase the rate at which drugs are developed, the mapping of diseases, and the application of personalized medicine, which has significant growth opportunities in the market by improving predictive modeling and simplifying the process of interpreting data.
To know more about the Epitranscriptomics Market - Download our Sample Report: https://marketgenics.co/download-report-sample/epitranscriptomics-market-70679
Expansion of Global Epitranscriptomics Market
"Innovation, and public funding propel the global epitranscriptomics market expansion"
The epitranscriptomics market is experiencing an impressive growth in the global market that is largely due to the unceasing innovations in the RNA sequencing technologies, single-cell analysis and high-throughput detection mechanism. These developments are allowing further understanding of RNA modifications, new biomarkers, and the creation of targeted treatment. An example of this is the STORM Therapeutics that administered the first patient in a clinical partnership investigating STC-15, an RNA modification inhibitor that targets METTL3, with LOQTORZI. The objective of the study is to determine safety and optimum dose/synergy of treatment with cancers like NSCLC and melanoma, and emphasize the therapeutic advantages of regulating RNA alterations to enhance treatment results.
The adoption of epitranscriptomics can be significantly stimulated through government and insurance incentives to lower the financial cost of research and clinical adoption, to facilitate the implementation of precision medicine efforts, and to increase the speed of the development and availability of RNA alteration-based diagnostics and therapies. Legal decisions like encouraging funding, reimbursement and ease of regulation access has emboldened academic institutions and biotech firms to invest in epitranscriptomic technologies and ultimately bring them into mainstream healthcare and translational research systems worldwide. As an example, the U.S. National Institutes of Health (NIH) and National Science Foundation (NSF) in 2024 declared a collaborative investment of 15.4 million dollars in RNA research, such as research into RNA modifications. This funding helps to advance technologies to learn more about RNA biology and its use in health and disease, and drive innovation in the field of epitranscriptomics.
Regional Analysis of Global Epitranscriptomics Market
The most promising market is the epitranscriptomics market in North America because of the well-established research infrastructure, the concentration of the major biotech and pharmaceutical companies, and the large amount of government and private funds dedicated to the research of RNA modification. The area is swiftly implementing modern technologies, including single-cell epitranscriptomics, high-throughput RNA sequencing, and AI-enhanced bioinformatics, which can be utilized to discover biomarkers and develop therapies more quickly. All these contribute to the advantages of translational research and development of RNA modification-based diagnostics and therapeutics, making North America a world leader in epitranscriptomics.
The Asia-Pacific market is projected to experience the greatest growth due to the increased government investments in biotechnology and RNA modification studies of countries like China, Japan, South Korea and India. The region has a rising number of academic and private research institutions, fast uptake of the latest sequencing technology, and a booming biotech startup ecosystem. An increased need of precision medicine and novel therapeutics is spurring the growth and clinical implementation of epitranscriptomic diagnostics and therapies.
Prominent players operating in the global epitranscriptomics market are Abcam, Active Motif, Agilent Technologies, Arraystar, Bio-Rad Laboratories, CD Genomics, Cell Signaling Technology, Creative Biolabs, EpiGentek, Epigentek Group, Genecopoeia, Illumina, LC Sciences, Merck KGaA, Moderna, Inc., New England Biolabs (NEB), Oxford Nanopore Technologies, Pacific Biosciences (PacBio), PerkinElmer, QIAGEN, Takara Bio, Thermo Fisher Scientific, Zymo Research, and Other Key Players.
Buy Now: https://marketgenics.co/buy/epitranscriptomics-market-70679
The global Epitranscriptomics market has been segmented as follows:
Global Epitranscriptomics Market Analysis, By Modification Type
m6A (N6-methyladenosine)
Writers (METTL3, METTL14)
Erasers (FTO, ALKBH5)
Readers (YTHDF proteins)
Others
m5C (5-methylcytosine)
Pseudouridine (Ψ)
m1A (N1-methyladenosine)
m7G (7-methylguanosine)
A-to-I Editing
Other Modifications
Global Epitranscriptomics Market Analysis, By Technology/Method
Sequencing-Based Methods
MeRIP-seq/m6A-seq
miCLIP
PA-m6A-seq
DART-seq
Others
Mass Spectrometry
LC-MS/MS
UHPLC-MS/MS
Others
Antibody-Based Detection
Chemical Labeling Methods
Nanopore Sequencing
Enzymatic Methods
Others
Global Epitranscriptomics Market Analysis, By Product Type
Kits & Reagents
RNA modification detection kits
Enrichment kits
Sequencing library preparation kits
Others
Instruments & Equipment
Software & Bioinformatics Tools
Services
Global Epitranscriptomics Market Analysis, By RNA Type
mRNA (Messenger RNA)
tRNA (Transfer RNA)
rRNA (Ribosomal RNA)
lncRNA (Long Non-coding RNA)
miRNA (MicroRNA)
circRNA (Circular RNA)
snRNA (Small Nuclear RNA)
Others
Global Epitranscriptomics Market Analysis, By Application
Disease Biomarker Discovery
Drug Target Identification
Therapeutics Development
mRNA therapeutics
Antisense oligonucleotides
Small molecule modulators
Others
Basic Research
Diagnostic Development
Personalized Medicine
Vaccine Development
Others
Global Epitranscriptomics Market Analysis, By Disease Area
Cancer/Oncology
Leukemia
Breast cancer
Lung cancer
Liver cancer
Others
Neurological Disorders
Alzheimer's disease
Parkinson's disease
Glioblastoma
Others
Metabolic Disorders
Obesity
Diabetes
Others
Cardiovascular Diseases
Infectious Diseases
Immunological Disorders
Others
Global Epitranscriptomics Market Analysis, By End-Use Industry
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Diagnostic Laboratories
Hospital & Clinical Laboratories
Others
Global Epitranscriptomics Market Analysis, By Workflow Stage
Sample Preparation
RNA Extraction & Purification
Modification Detection
Enrichment & Immunoprecipitation
Sequencing & Analysis
Data Interpretation
Global Epitranscriptomics Market Analysis, by Distribution Channel
Direct Sales
Distributors & Resellers
Online Channels
Global Epitranscriptomics Market Analysis, By Region
North America
Europe
Asia Pacific
Middle East
Africa
South America
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epitranscriptomics Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity here
News-ID: 4256922 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
Wearable AI Market to Reach USD 233.5 Billion by 2035 Amid Rising Demand for Sma …
According to the MarketGenics report, the global wearable AI market is likely to grow from USD 57.1 Billion in 2025 to USD 233.5 Billion in 2035 at a highest CAGR of 15.1% during the time period. The global wearables AI market is rapidly growing, and a number of factors are driving this change, but perhaps the most important of these factors is the desire for health and fitness tracking through…
Engineered Exosomes Market Forecast 2035 | Key Driver, Restraint, and Growth Opp …
A significant study discovering the market avenues on, "Engineered Exosomes Market Size, Share & Trends Analysis Report by Source/Origin (Plant-derived exosomes, Mammalian cell-derived exosomes, Bacterial exosomes, Yeast-derived exosomes Disorders, Stem cell-derived exosomes), Cargo Type, Engineering Method, Isolation/Production Method, Therapeutic Application, Diagnostic Application, Surface Modification, Product Type, End-users, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A holistic…
Enamel Technology Market Forecast 2035 | Product Type, Application, Technology T …
A significant study discovering the market avenues on, "Enamel Technology Market Size, Share & Trends Analysis Report by Product Type (Porcelain Enamel Coatings, Glass-lined Enamel, Specialty Enamel Formulations, Hybrid Enamel Systems), Application, Technology Type, Functional Properties, Substrate Material, End-user Facility Type, Processing Temperature, Distribution Channel, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A holistic view of…
Video Surveillance as a Service (VSaaS) Market Set to Surge to USD 16.3 Billion …
According to the MarketGenics report, the global VSaaS market is likely to grow from USD 4.7 Billion in 2025 to USD 16.3 Billion in 2035 at a highest CAGR of 13.2% during the time period. The VSaaS market is undergoing rapid expansion driven by rising need for intelligent, real-time monitoring solutions across various industries such as retail, transit, manufacturing, and smart cities. Organizations are increasingly turning to cloud-based surveillance platforms…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
